Molecular therapy for ectopic pregnancy
Author(s) -
Agus Cakhantara,
Aditya Prabawa
Publication year - 2019
Publication title -
bali anatomy journal
Language(s) - English
Resource type - Journals
eISSN - 2621-2021
pISSN - 2620-3154
DOI - 10.36675/baj.v2i2.27
Subject(s) - gefitinib , methotrexate , ectopic pregnancy , medicine , pregnancy , obstetrics , biology , cancer , genetics , epidermal growth factor receptor
Aim: The study aims to compare a combination of both gefitinib and methotrexate to methotrexate only in ectopic pregnancy. Review: Ectopic pregnancies are a serious condition that can be fatal, so the prompt therapeutic is essential. There were some recent studies explained the combination is more effective inducing placental cell death. They can rapidly resolve ectopic tubal pregnancy than single methotrexate only. If a large clinical randomized control trial confirms these finding, these combinations could become a new medical option for ectopic pregnancy. Conclusion: The combination of gefitinib and methotrexate is more effective than methotrexate one in ectopic pregnancy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom